Moran Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-644
| Closed | -$312K | – | 516 |
|
|
2025
Q1 | $312K | Sell |
644
-29,300
| -98% | -$14.2M | 0.01% | 397 |
|
|
2024
Q4 | $12.1M | Buy |
29,944
+866
| +3% | +$349K | 0.38% | 90 |
|
|
2024
Q3 | $13.5M | Buy |
29,078
+459
| +2% | +$213K | 0.42% | 83 |
|
|
2024
Q2 | $13.4M | Buy |
28,619
+1,274
| +5% | +$597K | 0.44% | 75 |
|
|
2024
Q1 | $11.4M | Buy |
27,345
+438
| +2% | +$183K | 0.37% | 92 |
|
|
2023
Q4 | $10.9M | Buy |
26,907
+1,962
| +8% | +$798K | 0.39% | 89 |
|
|
2023
Q3 | $8.67M | Buy |
24,945
+945
| +4% | +$329K | 0.34% | 107 |
|
|
2023
Q2 | $8.45M | Sell |
24,000
-445
| -2% | -$157K | 0.32% | 110 |
|
|
2023
Q1 | $7.7M | Buy |
24,445
+9,015
| +58% | +$2.84M | 0.29% | 118 |
|
|
2022
Q4 | $4.46M | Buy |
+15,430
| New | +$4.46M | 0.17% | 164 |
|